KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-9.16 Cr | ₹-0.88 Cr | ₹9.78 Cr | ₹-2.44 Cr | ₹9.70 Cr |
What is the latest Net Cash Inflow / Outflow ratio of KILITCH DRUGS (INDIA) ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-9.16 Cr |
| Mar2024 | ₹-0.88 Cr |
| Mar2023 | ₹9.78 Cr |
| Mar2022 | ₹-2.44 Cr |
| Mar2021 | ₹9.70 Cr |
How is Net Cash Inflow / Outflow of KILITCH DRUGS (INDIA) Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-9.16 Cr | Negative | |
| Mar2024 | ₹-0.88 Cr | Negative | |
| Mar2023 | ₹9.78 Cr | Positive | |
| Mar2022 | ₹-2.44 Cr | Negative | |
| Mar2021 | ₹9.70 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹584.0 Cr | -0.5% | -7.9% | 6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -0.5% |
-7.9% |
6.1% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses